Graduate students whiz around this slimy beating heart and crawl under the tubes connected to the apparatus cradling the organ as a Medtronic scientist prods a snaking tool around its interior. This ...

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

The U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm insulin pump, which is also a glucose monitor. The U.S. Food and Drug Administration has approved Medtronic's ...

What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...

Medtronic Plc is a medical technology company ... The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded ...